DA inhibits RANKL-induced osteoclast differentiation in vitro and ovariectomy-induced bone loss in vivo, and DA also controls the osteoclast/osteoblast ratio through its estrogenic effects, which has led to its development as an effective treatment for osteoporosis [19]. The gene discussed is TNFSF11; the disease is osteoporosis.